{"id":"W4408981555","doi":"10.1016/s1556-0864(25)00491-5","title":"299P: First-line (1L) durvalumab (D) + platinum-etoposide (EP) in extensive-stage SCLC (ES-SCLC): Final results and exploratory biomarker analyses from LUMINANCE","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Durvalumab; Etoposide; Oncology; Biomarker; Stage (stratigraphy); Internal medicine; Cancer; Nivolumab; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00114113,0.0004984874,0.0008965783,0.0003215101,0.000252946,0.0008950764,0.0004999316,0.0004330517,0.003692411],"category_scores_gemma":[0.001503788,0.0001890132,0.0009269984,0.0004729915,0.0002281392,0.0007474155,0.0003866772,0.000859237,0.001110936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001138286,"about_ca_system_score_gemma":0.0008862591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002598704,"about_ca_topic_score_gemma":0.006552273,"domain_scores_codex":[0.9995613,0.0001208979,0.00002767334,0.0001150369,0.0001010636,0.00007411323],"domain_scores_gemma":[0.9995035,0.000108145,0.00009683897,0.00006082528,0.00008433108,0.0001462604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1562844,0.002571058,0.2846478,0.00122573,0.004997511,0.0009069285,0.0002070696,0.002944884,0.02222632,0.0004044577,0.02412234,0.4994615],"study_design_scores_gemma":[0.03013487,0.03069115,0.8808624,0.0004692283,0.006316732,0.002816335,0.0002769564,0.003107534,0.01395573,0.0009528857,0.03032943,0.00008673173],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9745784,0.00633864,0.0005862372,0.0008251996,0.00009905961,0.0003910135,0.01132355,0.00009854862,0.005759273],"genre_scores_gemma":[0.9683877,0.002563635,0.001667893,0.0007548206,0.00006847839,0.0003120108,0.02291598,0.0000459665,0.003283452],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003692411,"threshold_uncertainty_score":0.01235235,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1280930871144411,"score_gpt":0.5083823957932491,"score_spread":0.3802893086788079,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}